The results revealed that EGCG up-regulated JWA while decreased topoisomerase IIα expression in both human non-small cell lung cancer (NSCLC) cells and an NSCLC xenograft mice model. The gene discussed is ARL6IP5; the disease is non-small cell lung carcinoma.